IntelGenx is a leading oral drug delivery company focused on the development and manufacturing of innovative pharmaceutical oral films based on its proprietary VersaFilm® technology platform. Established in 2003, the Montreal-based company is listed on the TSX-V and OTC-QX. IntelGenx’s highly skilled team provides comprehensive pharmaceutical services to partners, including R&D, analytical…More method development, clinical monitoring, IP and regulatory services. Established for the VersaFilm® technology platform, IntelGenx’s state-of-the art manufacturing facility supports lab-scale-to-pilot and commercial-scale production, offering full service capabilities to their clients.